Hyderabad is all set to host the second edition of the 'Indian Pharmacovigilance Day Conference 2017’on July 28 at Hotel Lemon Tree Premier in Hitech City.  The main aim of this event is to provide a platform for discussing pharmacovigilance issues specific to Indian contest. Dr J Vijay Venkatraman, Managing Director & Chief Executive Officer of Oviya MedSafe, a global Pharmacovigilance consulting and Drug Safety services provider from Coimbatore is expected to chair this big event in Hyderabad.

According to Enrico Pedroni, managing director of EasyB srl, the organizer of the event, the one-day conference has been designed to benefit functional, technical professionals working in the pharmacovigilance, regulatory, medical affairs,  marketing domains in organizations involved in pharmaceutical manufacturing, drug marketing,  contract research, healthcare professionals in patient care, clinical investigators & research staff, academia and government health agencies, among others.

‘Pharmacovigilance Day’ was first launched in London in the year 2015. However, the first edition of Indian Pharmacovigilance Day Conference began only in the year 2016 and since then Dr. Venkatraman has been chairing the event during all the 3 consecutive years since its launch. “It’s a great honour to chair all the 3 consecutive Pharmacovigilance Day conferences since its inception. I would say this platform is a great learning experience to all stakeholders relating to the pharmaceutical industry”, said Dr. Venkataraman.

While speaking about Indian pharma industry and new developments in pharmacovigilance sector, Dr Venkatraman said, “Of late, India is also being seen as a target destination for procurement of support services required for the global pharmaceutical industry, especially in pharmacovigilance. Simultaneously, we have seen changes for the better in Indian pharmacovigilance such as XML-E2B format reporting of ICSRs to the Pharmacovigilance Programme of India (PvPI) and the March 8th 2016 dated gazette notification legally mandating pharmacovigilance for all pharmaceutical companies. With news of the revised draft of the ‘Pharmacovigilance Guidelines for Marketing Authorization Holders of Pharmaceutical Products in India’ being close to finalization by the Indian regulatory authorities, understanding pharmacovigilance is now a compelling need for all the stakeholders in India.”

In view of the new developments coming up in pharmacovigilance sector, the Indian Pharmacovigilance Day 2017 conference is all set to integrate and streamline the opinions and expectations of all stakeholders achieve the formidable goal.

During the conference, expert speakers from the industry, health authorities, research bodies, academia and healthcare delivery centers will share their perspectives on the multifaceted outlook of the discipline of pharmacovigilance in India and deliberate on the challenges they expect to face in 2017, covering several aspects of pharmacovigilance that India is involved in.